Down’s syndrome treatable in side mom’s

According to the study published in the Obstetrics and Gynaecology, the injection of two key proteins, NAP and SAL, in to the womb of pregnant mice prevents from developing mental disorders in the offspring.

Previous studies had reported that the malfunction of the cerebral cell responsible for the production of NAP and SAL contributes to Down’s syndrome. These two proteins help regulate the development of nerve cells.

Moreover, ADNP, a regulatory protein, is not sufficiently produced by Down’s-affected glial cells.

Findings revealed that the injection of nerve-protecting chemicals prevented some of the damage to the extra chromosome, indicating that not only developmental delay was not reported in these mice, but also normal levels of ADNP was found in the brains of the treated mice.

Scientists are optimistic that the findings of the present study will pave the way for treating infants at high risk of developing Down’s syndrome before they are born.

Down’s syndrome, caused in children who inherit an extra copy of chromosome 21, is characterized by heart and developmental problems along with learning difficulties. The incidence of the condition has considerably increased.